Remove Events Remove High Tech Remove Study Remove Technical Review
article thumbnail

Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More

Xconomy

. —Alnylam Pharmaceuticals (NASDAQ: ALNY ) of Cambridge, MA, said that it would shelve its drug revusiran after 18 patients died in a Phase 3 study to treat the rare disease transthyretin amyloidosis. —The 2016 Nobel Prize for Physiology or Medicine went to Yoshinori Ohsumi of the Tokyo Institute of Technology.

article thumbnail

What Can You Learn from the 4-Hour Workweek?

Both Sides of the Table

If you’re not familiar with the term it’s basically trying to help all of us who are deluged with technology to find ways to cope with the masses of information without having it ruin our lives. We were high tech at the very start of the boom. If you always planned to study a second language – START!

Startup 295